ANI PHARMACEUTICALS, INC (ANIP) Free cash flow 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$171.4MFY2025 · since FY2016: $22.9M → $171.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $171.4M | +258.7% |
| FY2024 | $47.8M | -56.6% |
| FY2023 | $110.1M | +374.7% |
| FY2022 | -$40.1M | -5339.1% |
| FY2021 | $765,000 | -91.6% |
| FY2020 | $9.1M | -76.6% |
| FY2019 | $39.0M | -36.4% |
| FY2018 | $61.3M | +111.1% |
| FY2017 | $29.1M | +26.8% |
| FY2016 | $22.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice